OFIX Orthofix Medical Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: OFIX

Price (delayed)

$9.115

Market cap

$368.44M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.5

Enterprise value

$481.96M

?
Relative Growth: Rel. Growth: 51
Relative Strength: Rel. Strength: 12
Relative Valuation: Rel. Valuation: 43
Relative Profitability: Rel. Profitability: 44

Orthofix Medical Inc. is a global medical device and biologics company with a spine and extremities focus. The Company's mission is to deliver innovative, quality-driven solutions as it partners with ...

Highlights
The EPS has soared by 59% YoY and by 36% from the previous quarter
The net income has soared by 58% YoY and by 35% from the previous quarter
Orthofix Medical's debt has increased by 34% from the previous quarter and by 34% YoY
The equity has contracted by 5% YoY and by 3.3% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://www.orthofix.com
Peers: ATEC SYK GMED

Key stats

What are the main financial stats of OFIX

OFIX stock price

How has the Orthofix Medical stock price performed over time
Intraday
1.84%
1 week
-3.13%
1 month
-15.21%
1 year
-15.6%
YTD
-39.87%
QTD
-20.53%

Financial performance

How have Orthofix Medical's revenue and profit performed over time
Revenue
$825.37M
Gross profit
$583.94M
Operating income
-$46.99M
Net income
-$60.01M
Gross margin
70.7%
Net margin
-7.3%
Orthofix Medical's net margin has soared by 59% YoY and by 35% from the previous quarter
The net income has soared by 58% YoY and by 35% from the previous quarter
The company's operating margin has surged by 56% YoY and by 42% QoQ
The company's operating income has surged by 55% YoY and by 42% QoQ

Price vs fundamentals

How does OFIX's price correlate with its fundamentals

Growth

What is Orthofix Medical's growth rate over time

Valuation

What is Orthofix Medical stock price valuation
P/E
N/A
P/B
0.84
P/S
0.45
EV/EBIT
N/A
EV/EBITDA
31.06
EV/Sales
0.58
The EPS has soared by 59% YoY and by 36% from the previous quarter
The stock's price to book (P/B) is 36% less than its 5-year quarterly average of 1.3 and 31% less than its last 4 quarters average of 1.2
The equity has contracted by 5% YoY and by 3.3% from the previous quarter
The price to sales (P/S) is 51% lower than the 5-year quarterly average of 0.9 and 27% lower than the last 4 quarters average of 0.6
The revenue is up by 2.6% year-on-year

Efficiency

How efficient is Orthofix Medical business performance
The ROS has soared by 64% YoY and by 44% from the previous quarter
The ROIC has soared by 64% YoY and by 46% from the previous quarter
OFIX's return on assets has surged by 58% year-on-year and by 36% since the previous quarter
OFIX's ROE has soared by 52% YoY and by 34% QoQ

Dividends

What is OFIX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for OFIX.

Financial health

How did Orthofix Medical financials performed over time
The total assets is 96% greater than the total liabilities
Orthofix Medical's quick ratio has increased by 24% QoQ and by 21% YoY
The company's total liabilities rose by 24% YoY and by 13% QoQ
Orthofix Medical's debt is 46% less than its equity
OFIX's debt to equity is up by 42% YoY and by 38% from the previous quarter
Orthofix Medical's debt has increased by 34% from the previous quarter and by 34% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.